Description

Indication & Scope

Qiyoukang contains gumokimab, a humanized anti-IL-17A monoclonal antibody for the treatment of moderate-to-severe plaque psoriasis.

Mechanism: Neutralizes IL-17A and inhibits IL-17/IL-17 receptor signaling, reducing pro-inflammatory cytokine release.
Drug class: Humanized anti-IL-17A monoclonal antibody.
Clinical use: Treatment of moderate-to-severe plaque psoriasis.

Specification

Generic Name	Gumokimab
Brand Name	QiYouKang®
Ingredient	Each prefilled syringe contains 100 mg gumokimab in 1 mL
Dosage Form	Prefilled Syringe
Package	One prefilled syringe (1 mL)
Conditions Treated	Treatment of moderate-to-severe plaque psoriasis in adults eligible for systemic therapy
Taboos	Hypersensitivity to clesrovimab or any component of the product
Place of origin	China
Prescription type	Prescription Drug (Rx)
Storage Conditions	Store refrigerated at 2°C–8°C. Do not freeze. Protect from light. Do not shake.
Manufacturer	Akeso, Inc.
Registration Authority	National Medical Products Administration (NMPA), China
Approval number	BLA 761420
Date of Revision	2026
Shelf Life	Refer to the approved package labeling

How to use ?

Recommended Dose: 100 mg administered by subcutaneous injection once every 4 weeks.

Time: Administer according to the approved dosing schedule.

Instructions for use: Administer by subcutaneous injection using the prefilled syringe. Allow the product to reach room temperature before administration. Do not shake. Rotate injection sites when multiple injections are required.

Interaction: No clinically significant drug interactions have been identified.

Side effects: Upper respiratory tract infection, injection-site reactions, elevated liver enzymes, and neutropenia.

Important Notice

This product should be administered only by qualified healthcare professionals in accordance with the approved prescribing information and local clinical guidelines. Dosage and administration may vary depending on patient condition, indication, and regional regulatory requirements.

Packaging & Shipping

Packaging

Original manufacturer’s packaging with secure export carton. Customized export packaging is available upon request.

Shipping Methods

Express Courier (EMS, DHL, FedEx, UPS), Air Freight, and Sea Freight. Cold-chain transportation is available for products requiring temperature-controlled logistics.

Export Support

Certificate of Analysis

GMP Certificate

Commercial Invoice

Packing List & CPP

Cold Chain Logistics

Customs Documentation

Scientific and regulatory sources

1.WHO References

2.NMPA

3.FDA

4.EMA

FAQ

What is the mechanism of action of the drug gumokimab?

Gumokimab is a humanized monoclonal antibody that specifically binds to IL-17A. It competitively blocks the IL-17/IL-17R signaling cascade, thereby suppressing the initiation and progression of autoimmune inflammatory responses associated with plaque psoriasis and spondyloarthritis.

What is the mechanism of action of gumokimab?

Gumokimab binds to IL-17A and inhibits IL-17A-mediated inflammatory signaling involved in psoriasis pathogenesis.

Who is Qiyoukang® indicated for?

It is indicated for adults with moderate-to-severe plaque psoriasis who are candidates for systemic therapy.

How should Qiyoukang® be stored?

Store refrigerated at 2°C–8°C, protect from light, and do not freeze or shake.